Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By white_Tiger (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Another Well-Deserved Hat Tip To Our Contributors [GeoWire Weekly No. 137]

% of readers think this story is Fact. Add your two cents.


Welcome to The GeoWire , your source for a Peek into GeoInvesting’s Research Coverage, Microcap Stock Education, Case Studies, Featured Videos, and More. Please share this if you like today’s newsletter and comment with any feedback.


If you are new or this was shared with you, you can join our email list here.

While the majority of our microcap research is generated  in-house, we believe in the power of research collaboration and the strength of our GeoInvesting contributor community that’s been cultivated over the last 16 years. Our success is not just measured by the performance of the stocks we research and wear on our sleeves, but by the dedicated authors who selflessly pitch their own ideas, enriching our collective investment knowledge.

By the way, although Jeremy Diller is not on the list of authors we will be highlighting, we need to give him a special accolade on his monster bullish call on $NYWKF (NCI.V). Jeremy actually reached out to me in October 2023 to pitch the idea to me. I unfortunately passed on the Idea and the  stock is now up 167%. You can read their Q1 2024 earnings report that was just released today, here.

Before we dive into our appreciation of the returns of some outstanding contributions, we did want to address the unleashing of the potential energy that one of our favorites, Tss Inc (OOTC:TSSI), has been storing since it was added to our Select Coverage Universe.

Now that the cat is out of the bag, investors have widely noticed the message TSSI has been telegraphing in parallel with the data center boom that appears to be here to stay. While we liked TSSI for multiple reasons, the company’s harnessing of the low-hanging-fruit opportunities right in front of them is still a story that is unfolding, but nonetheless has produced a 633% return from it’s low of $0.27 in February to its closing price of $1.98 a few days ago.

We understand that the stock is hard to value, but are by no means surprised by the run, especially given the very sharp, yet subtle, messaging  that management has delivered to showcase TSSI’s capabilities and its place in Data Center infrastructure buildout trends, possibly alongside Dell Technologies Inc. (NYSE:DELL) and its AI Data Center “partner,” Nvidia Corporation (NASDAQ:NVDA)

Pivoting back to our contributors, we wanted to use this week to briefly tip our hats to the talented individuals who provided insights into companies that have shown some impressive returns this year.

Here’s just a sample of some of the year to date returns from stocks in our Contributor Index:

Contributors ytd 5-27-2024

As you can see, three stocks are up over 200% this year, with one of them being a very recent addition that was pitched during GeoInvesting’s April 3, 2024 live Open Forum, ASPI.

Maj visited the subject of Asp Isotopes Inc. with contributor Matt S., who discussed the company’s niche technology in isotope separation, vital for both the medical and energy sectors. He explained that the company’s unique method for producing high-purity isotopes has applications ranging from cancer treatment to nuclear energy, positioning it in a market with limited competition and significant growth potential. Even though ASPI is a speculative story, we found Matt’s summarization of the opportunity to be interesting.

(by the way, Matt‘s other pitch, ZENV, has also done well, but he just reached out to us to let us know he exited the position and may look to reenter at some point).

ASPI’s initial products, Carbon-14 and Molybdenum-100, have specialist uses, and the company’s marketing strategy and upcoming catalysts make it a stock to watch. One major catalyst is the planned spin-out of Quantum Leap Energy, which will focus on uranium HALEU enrichment, a critical component for Small Modular Reactors (SMRs) in the US and UK. This spin-out is expected to be financed through customer funding and project debt, with Iceland as a potential location due to its cheap energy supply.

At the time of Matt’s pitch, insiders owned over half the shares and the stock had a market cap just under $200 million (now, it’s $280 million). Matt believes that ASPI also has the potential to be included in the Russell 2000 index if its price continues to outperform. Matt contended that this inclusion, coupled with increasing interest from uranium-focused investors, positions ASPI for significant re-rating.

We are immensely proud of our community, and we want to continue fostering an environment where great ideas thrive. To all our authors, thank you for your unwavering commitment and outstanding contributions. Keep the ideas coming – your next pitch could be the game-changer we’re all looking for!

We have some exciting ideas on how to ensure that contributor pitches will be best of breed pitches. We will let you know how that progress goes. 

Together, let’s continue to uncover the hidden gems.

—–

GeoInvesting Weekly Premium Email And Call To Action Updates (May 20 – May 24)

Morning Email Highlights Notable Updates

  • KTEL – Rehashing some InfoArb buried in 10-K filing 
  • BIOYF (RX.V) – Highlighting Q1 2024 results; EPS rises 50%; Doubles analyst estimate
  • TSSI – DELL’s servers for Nvidia’s chips could bode well for future growth
  • ALAR – Huge Q1 EPS on 47% revenue growth; AI Screen
  • TATT – Strong Q1 results and expects momentum to continue; Continues to secure significant long-term contracts ($40M) as part of its transformation to increase business visibility and more recurring revenue.
  • PXHI – Down Q1 results but sees reversal in negative trends; Share repurchases continue.
  • TGEN – Director continues to aggressively buy shares in the open market.

email-icon Premium Emails Sent During The Week

05/20/2024

BIOYF (RX.V) Q1 Does Not Disappoint; Highlighting Past KTEL Commentary 

Stocks : BIOYF, KTEL

Highlights KTEL – Rehashing some InfoArb buried in 10-K filing BIOYF (RX.V) – Highlighting Q1 2024 results; EPS rises 50%; Doubles analyst estimate – ** Notable News/Commentary On Model Portfolio Holdings Konatel Inc (NASDAQ:KTEL) ($0.70; $30.5M market cap) – Last week KTEL reported strong Q1 2024 results which we highlighted here. While reviewing…see more

05/21/2024

Connecting More TSSI Dots with Latest DELL/Nvidia News; Strong ALAR Q1 2024 

Stocks : TSSI, ALAR

Highlights TSSI – DELL’s servers for Nvidia’s chips could bode well for future growth ALAR – Huge Q1 EPS on 47% revenue growth; AI Screen — ** Notable News/Commentary On Model Portfolio Holdings Tss Inc (OOTC:TSSI) ($1.48, $32.6M market cap) – Interesting Reuters article yesterday regarding Dell’s latest line of servers which are…see more

05/22/2024

Contributor Posits USAQ Is An Undervalued Medtech Company at an Inflection Point 

Stocks : USAQ

Last night, GeoInvesting Premium Member and Contributor Todd Schuh published a pitch on Qhslab Inc (OOTC:USAQ). Please find the article here. The article covered some of the following points: Business Focus: QHSLab provides digital healthcare solutions and diagnostic tests to primary care physicians, improving patient care and practice revenues. Market Opportunity: Targeting independent primary care practices, QHSLab’s products can add $200,000 annually per doctor, enhancing profitability significantly. Financial Performance: In Q1…see more

05/23/2024

TATT and PXHI Encouraging Q1 2024 Comments; More TGEN Insider Purchases 

Stocks : TATT, PXHI, TGEN

Highlights TATT – Strong Q1 results and expects momentum to continue; Continues to secure significant long-term contracts ($40M) as part of its transformation to increase business visibility and more recurring revenue. PXHI – Down Q1 results but sees reversal in negative trends; Share repurchases continue. TGEN – Director continues to aggressively buy shares in the open market. – ** Notable News/Commentary On Model Portfolio…see more

The post Another Well-Deserved Hat Tip To Our Contributors [GeoWire Weekly No. 137] appeared first on GeoInvesting.


Source: https://geoinvesting.com/another-well-deserved-hat-tip-to-our-contributors/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.